(1) Except as otherwise provided in this section, beginning June 1, 2018, before a controlled substance that is an opioid is prescribed to a patient, a licensed prescriber or another health professional shall provide information on all of the following to the patient or the patient’s representative:

    (a) The danger of opioid addiction.

    (b) How to properly dispose of an expired, unused, or unwanted controlled substance.

    (c) That the delivery of a controlled substance is a felony under Michigan law.

    (d) If the patient is pregnant or is a female of reproductive age, the short- and long-term effects of exposing a fetus to a controlled substance, including, but not limited to, neonatal abstinence syndrome.

    (2) After providing the information described in subsection (1), the licensed prescriber or other health professional shall obtain the signature of the patient or the patient’s representative on a form prescribed by the department of health and human services, indicating that the patient or the patient’s representative has received the information described in subsection (1). The licensed prescriber or other health professional shall include the signed form in the patient’s medical or clinical record.

    (3) This section does not apply if the controlled substance described in subsection (1) is prescribed for inpatient use.

    (4) As used in this section:

    (a) “Health professional” means an individual who is licensed, registered, or otherwise authorized to engage in a health profession under article 15.

    (b) “Patient” means an individual who receives health care from the licensed prescriber.

    (c) “Patient’s representative” means a guardian of a patient, if appointed, or a parent, guardian, or person acting in loco parentis, if the patient is a minor, unless the minor lawfully obtained health care without the consent or notification of a parent, guardian, or other person acting in loco parentis.